<DOC>
	<DOCNO>NCT00196924</DOCNO>
	<brief_summary>Human Papilloma virus ( HPV ) viruses cause common infection skin genitals men woman . Several type HPV infection transmit sexual activity , woman , infect cervix ( part uterus womb ) . This infection often go away , go away ( call persistent infection ) , lead woman long period time cancer cervix . If woman infect HPV , unlikely get cervical cancer . This study evaluate safety immunogenicity GSK Biologicals HPV-16/18 vaccine 12 month , pre-teen adolescent woman 10-14 year age study start . Approximately 2000 study subject receive HPV vaccine control vaccine ( hepatitis A vaccine ) administer intramuscularly accord 0-1-6 month schedule .</brief_summary>
	<brief_title>Human Papilloma Virus Vaccine Safety Immunogenicity Trial Young Adolescent Women With GSK Bio HPV-16/18 .</brief_title>
	<detailed_description />
	<criteria>A woman , include , 10 14 year age time first vaccination . Written inform consent subject prior enrolment . Subject must free obvious health problem . Subject must negative urine pregnancy test . Pregnant breastfeeding . Known acute chronic , clinically significant pulmonary , cardiovascular , neurologic , hepatic renal functional abnormality . History chronic condition ( ) require treatment cancer , chronic hepatitis kidney disease ( ) , diabetes , autoimmune disease . Previous vaccination human papillomavirus ( HPV ) .</criteria>
	<gender>Female</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>